医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2014年
29期
108-108
,共1页
尼莫地平%眩晕%钙离子拮抗剂%疗效
尼莫地平%眩暈%鈣離子拮抗劑%療效
니막지평%현훈%개리자길항제%료효
Nimodipine%Vertigo%Calcium antagonists%Curative ef ect
目的：是探讨尼莫地平治疗眩晕症的疗效。方法结合患者实际情况给予尼莫地平首次剂量20~40mg，之后20mg/次，3次/d，症状控制后再服2~3d。结果尼莫地平在治疗眩晕症中有较为显著的疗效其中120例患者，显效71%，有效24%，无效5%。结论通过临床实践尼莫地平在治疗眩晕症方面有较显著的效果，且副作用小，安全性高，值得临床推广。
目的：是探討尼莫地平治療眩暈癥的療效。方法結閤患者實際情況給予尼莫地平首次劑量20~40mg，之後20mg/次，3次/d，癥狀控製後再服2~3d。結果尼莫地平在治療眩暈癥中有較為顯著的療效其中120例患者，顯效71%，有效24%，無效5%。結論通過臨床實踐尼莫地平在治療眩暈癥方麵有較顯著的效果，且副作用小，安全性高，值得臨床推廣。
목적：시탐토니막지평치료현훈증적료효。방법결합환자실제정황급여니막지평수차제량20~40mg，지후20mg/차，3차/d，증상공제후재복2~3d。결과니막지평재치료현훈증중유교위현저적료효기중120례환자，현효71%，유효24%，무효5%。결론통과림상실천니막지평재치료현훈증방면유교현저적효과，차부작용소，안전성고，치득림상추엄。
Objective To investigate the ef icacy of the nimodipine treatment of vertigo. Methods In combination with the practical situation of patients give nimodipine 20 to 40 mg dose for the first time after 20 mil igrams at a time 3 times a day Symptom control again after 2~3 days. Results The nimodipine in the treatment of vertigo in relatively remarkable curative ef ect of 120 patients Ef ective in 71%, ef ective 24%, invalid 5%. Conclusion Through clinical practice Nimodipine has a significant ef ect in treatment of vertigo, and side ef ects of smal , high safety, worth clinical promotion.
